EMA – New EU rules for health technology assessments become effective
EMA is ready to support the implementation of the new regulation on health technology assessment (HTAR) (Regulation (EU) 2021/2282) when it becomes applicable on 12 January 2025.
The regulation is an important step forward in accelerating and widening access to new medicines. In the European Union (EU), a centrally authorised medicine is accessible to patients when it has first gone through regulatory assessment by EMA and is authorised for use in patients, and secondly been evaluated by health technology assessment (HTA) bodies to help Member States take decisions about the use, price and reimbursement level of a new health technology taking into account its impact on the sustainability of the healthcare systems.
More information on the EMA Website.
OpenEdition vous propose de citer ce billet de la manière suivante :
vroby (25 mars 2025). EMA – New EU rules for health technology assessments become effective. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/13kg5





